Artificial intelligence (AI) is rapidly becoming part of clinical practice, including aesthetics. From online triage forms and consultation support tools like note-taking to skin analysis and treatment planning systems, AI is now influencing how patients research clinics, assess treatments and make decisions.
But while AI is often discussed as something futuristic, much of it is already quietly embedded within everyday business systems. Many clinics are already using AI without necessarily thinking of it that way – whether through automated booking systems, chatbot functions, consultation note software or content tools.
The challenge for practitioners is not simply whether to use AI, but how to use it safely, responsibly and in a way that supports patient care rather than undermines it.
Because ultimately, while AI can support decision-making, it cannot take responsibility for it.
Understanding the insurance implications of AI use in clinical practice is becoming increasingly important as more clinics adopt automated systems, particularly within the UK medical malpractice aesthetics sector, where practitioners remain legally accountable for treatment outcomes regardless of the technology used.
For more on this, read our guide to AI in aesthetic practice: What it means for insurance and liability.
One of the biggest shifts AI is creating is not necessarily inside the consultation room, but before the patient even arrives.
Patients are increasingly using AI-powered search and recommendation tools to research clinics, compare practitioners and ask detailed treatment questions. Rather than simply searching “botulinum toxin clinic near me”, patients are now asking far more nuanced questions around expertise, safety, outcomes and complications.
As aesthetics business coach and mentor Ron Myers explained during a recent Hamilton Fraser podcast discussion on AI in aesthetics, these systems are beginning to assess clinics based on the depth and quality of their information, rather than simply who appears highest in paid search results.
That creates both opportunities and risks for clinics. Strong educational content, evidence of experience and clear patient information are becoming increasingly important. At the same time, exaggerated claims, overly promotional language and unrealistic expectations may become easier for patients and AI systems to identify.
AI is also increasingly embedded within front-end patient journeys, often being used before or during consultation to help streamline processes and improve communication.
From consultation support to treatment planning
Within clinics themselves, AI is increasingly being used to support patient assessment, treatment planning and operational workflows.
In practical terms, this can include:
Importantly, most current systems are assistive rather than autonomous. They are designed to support clinicians by organising information, identifying patterns and streamlining workflows.
As Myers noted in the podcast, AI works best when viewed as a tool that helps clinics “think, create, communicate, analyse and automate” more effectively, rather than something designed to replace practitioners altogether.
Some systems may suggest potential treatment approaches based on patient information provided, identify possible contraindications or flag areas of elevated risk. Others may help generate consultation summaries, treatment plans or follow-up recommendations.
This distinction matters from both a patient safety and insurance perspective. AI can summarise consultation notes. It can identify trends within patient data. It can even help clinics improve communication and follow-up processes.
But it does not replace clinical judgement.
From a legal and insurance perspective, the position remains clear: responsibility sits with the practitioner and the clinic.
AI does not hold indemnity. Software cannot accept liability if something goes wrong.
As Ron Myers put it during the discussion, “AI doesn’t have the indemnity – the clinic does.”
That means practitioners remain fully responsible for all clinical decisions, even where AI tools are involved in the process. Responsibility cannot be delegated to software tools.
This is particularly important as clinics begin introducing more automation into patient communication, treatment planning and operational systems. While AI may help generate consultation summaries, recommend workflows or assist with documentation, practitioners must still review, validate and approve information before it reaches the patient record or informs treatment decisions.
The principle is simple: AI may draft, but the practitioner signs off and remains accountable.
From an insurance perspective, practitioners should also consider how AI tools are being integrated into their workflows and whether their use could affect claims investigations in the future. In the event of a complaint or medical malpractice claim, insurers may examine the extent to which AI influenced decision-making, whether appropriate clinical oversight was maintained and whether consultation records clearly documented the practitioner’s reasoning.
This reinforces the importance of “human-in-the-loop” decision-making, where AI supports rather than replaces independent clinical judgement.
One emerging challenge is the role AI may play in shaping patient expectations.
Image manipulation and morphing technology have existed in aesthetics for years, but AI tools are making this increasingly accessible and sophisticated. Patients are also becoming more informed or sometimes misinformed through AI-generated treatment information online.
Clinics should also consider whether patients fully understand when AI tools are being used within consultations, imaging or treatment planning. Where AI-generated assessments, morphing tools or predictive outcomes form part of the consultation process, practitioners should make sure patients understand these are advisory tools rather than guarantees of outcome.
Clear consent discussions and documentation remain essential.
At Hamilton Fraser, there are already signs that complaints are becoming more complex and more formally structured, with AI-generated correspondence increasingly appearing in disputes and dissatisfaction cases.
This places even greater importance on robust consultation processes, accurate documentation and realistic expectation management.
If clinics choose to use AI-generated imaging, predictive outcome tools or automated communication systems, appropriate disclaimers and clear patient discussions become essential. A digitally generated “possible outcome” should never be presented as a guaranteed result.
Similarly, AI-generated clinical notes or treatment summaries should always be reviewed carefully by the practitioner before being added to the patient record.
While AI may improve efficiency, it also introduces new professional indemnity AI risk considerations for clinics and practitioners.
The highest-risk area remains anything directly linked to clinical decision-making.
AI should not independently assess patients, recommend treatments or replace practitioner oversight within consultations.
Risks can also arise where AI systems are working from incomplete, inaccurate or biased information. For example, poor-quality patient photographs, limited medical history data or inaccurate consultation inputs may affect the reliability of AI-generated recommendations.
There is also a risk that practitioners become over-reliant on automated suggestions without applying sufficient independent clinical judgement. Misinterpretation of AI-generated insights could ultimately contribute to inappropriate treatment planning, patient dissatisfaction or formal complaints.
As AI adoption increases across healthcare in the UK, questions around AI liability in healthcare UK settings are becoming increasingly relevant for aesthetic practitioners and clinic owners.
Potential consequences may include:
This is where AI decision-making insurance risk becomes particularly important. In the event of a claim, documentation of clinical reasoning and evidence of practitioner oversight may become increasingly significant.
There are also important data protection considerations. Patient information should only ever be used within secure, GDPR-compliant systems, and clinics should make sure staff understand appropriate use policies. Informal use of consumer AI tools with patient information could create significant regulatory and insurance concerns.
Top tips for safer AI use in aesthetic practice
Here are some practical steps clinics can take to reduce AI in aesthetics risk:
AI is unlikely to be a passing trend within aesthetics. Over time, it will probably become part of the everyday infrastructure of clinic operations in much the same way that online booking systems, digital photography and CRM platforms already have.
But despite the pace of change, the fundamentals remain the same.
Patients still expect safe care, honest communication and professional judgement. Regulators and insurers still expect practitioners to act responsibly and maintain clear records. And when something goes wrong, accountability still sits with the practitioner and the clinic – not the technology.
For aesthetic businesses, the challenge now is not whether to engage with AI, but how to do so safely, transparently and with appropriate clinical oversight.
For more guidance on managing clinical risk, complaints and AI insurance implications within aesthetic practice, read Hamilton Fraser’s guide to AI in aesthetics.
You can also speak to our specialist team on 0800 63 43 881 or get an online quote today.
